Catalyst Wire Dossier Catalyst Wire Dossier

AAV gene therapy for Phenylketonuria (PHEdom)

AAV-mediated gene therapy · NGGT INC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV gene therapy for Phenylketonuria (PHEdom), covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom) [Phase 1, Phase 2]

See pricing